An integrative analysis of Qingfei Paidu Decoction for its anti-HCoV-229E mechanism in cold and damp environment based on the pharmacokinetics, metabolomics and molecular docking technology
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An integrative analysis of Qingfei Paidu Decoction for its anti-HCoV-229E mechanism in cold and damp environment based on the pharmacokinetics, metabolomics and molecular docking technology
Authors
Keywords
-
Journal
PHYTOMEDICINE
Volume 108, Issue -, Pages 154527
Publisher
Elsevier BV
Online
2022-10-27
DOI
10.1016/j.phymed.2022.154527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PDE4D targeting enhances anti-tumor effects of sorafenib in clear cell renal cell carcinoma and attenuates MAPK/ERK signaling in a CRAF-dependent manner
- (2022) Minghua Cao et al. Translational Oncology
- Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
- (2021) Hongbo Liu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Plasma metabolomic profiling of patients recovered from COVID-19 with pulmonary sequelae 3 months after discharge
- (2021) Juanjuan Xu et al. CLINICAL INFECTIOUS DISEASES
- Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
- (2021) Mary EW Collier et al. DRUG DISCOVERY TODAY
- Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology
- (2021) George Anderson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes
- (2021) Ceren Guney et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications
- (2021) Nan Xiao et al. Nature Communications
- Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial
- (2021) Paul C Cremer et al. Lancet Rheumatology
- Knock-In Mice Expressing a 15-Lipoxygenating Alox5 Mutant Respond Differently to Experimental Inflammation Than Reported Alox5−/− Mice
- (2021) Eugenia Marbach-Breitrück et al. Metabolites
- Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
- (2020) Bo Shen et al. CELL
- Respiratory virus infections: Understanding COVID-19
- (2020) Kanta Subbarao et al. IMMUNITY
- Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China
- (2020) Erdan Luo et al. Chinese Medicine
- Plasma Metabolomic and Lipidomic Alterations Associated with COVID-19
- (2020) Di Wu et al. National Science Review
- ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases
- (2020) Ravindra K. Sharma et al. HYPERTENSION
- Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients
- (2020) Tiffany Thomas et al. JOURNAL OF PROTEOME RESEARCH
- Pathological angiogenesis and inflammation in tissues
- (2020) Ji-Hak Jeong et al. ARCHIVES OF PHARMACAL RESEARCH
- Microbes, metabolites, and the gut–lung axis
- (2019) Anh Thu Dang et al. Mucosal Immunology
- The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
- (2018) Harald Hampel et al. BRAIN
- Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study
- (2018) Samuel S. Gidding et al. JOURNAL OF PEDIATRICS
- Amino-acid transporters in T-cell activation and differentiation
- (2017) Wenkai Ren et al. Cell Death & Disease
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started